The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression

Phenserine Efficacy in Alzheimer's Disease

(2017) Bengt Winblad et al.   JOURNAL OF ALZHEIMERS DISEASE

The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen

(2011) Jack T. Rogers et al.   JOURNAL OF NEURAL TRANSMISSION

Synuclein deposition and non-motor symptoms in Parkinson disease

(2011) Kurt A. Jellinger   JOURNAL OF THE NEUROLOGICAL SCIENCES

Alpha-Synuclein Is a Cellular Ferrireductase

(2011) Paul Davies et al.   PLoS One

Evaluating Rivastigmine in Mild-to-Moderate Parkinson’s Disease Dementia Using ADAS-Cog Items

(2010) Frederick A. Schmitt et al.   American Journal of Alzheimers Disease and Other Dementias

The Synucleins Are a Family of Redox-Active Copper Binding Proteins

(2010) Paul Davies et al.   BIOCHEMISTRY

Cognition and olfaction in Parkinson’s disease

(2010) Ronald Postuma et al.   BRAIN

The Treatment of Cognitive Impairment Associated with Parkinson's Disease

(2010) David J. Burn   BRAIN PATHOLOGY

Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease

(2010) James A. Duce et al.   CELL

Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia

(2010) Frederick A. Schmitt et al.   CNS Neuroscience & Therapeutics

Rivastigmine in the Treatment of Dementia Associated with Parkinson’s Disease: Effects on Activities of Daily Living

(2010) Jason T. Olin et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Cholinesterase inhibitors: beyond Alzheimer’s disease

(2010) AJ Larner   Expert Review of Neurotherapeutics

Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes

(2010) Yien-Ming Kuo et al.   HUMAN MOLECULAR GENETICS

Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1

(2010) Hyun-Hee Cho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

(2010) D. O. Claassen et al.   NEUROLOGY

Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

(2009) Orly Weinreb et al.   Genes and Nutrition

Physiological and Pathological Role of Alpha-synuclein in Parkinson’s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element

(2009) David Olivares et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Molecular and immunocytochemical characterization of primary neuronal cultures from adult rat brain: Differential expression of neuronal and glial protein markers

(2009) Balmiki Ray et al.   JOURNAL OF NEUROSCIENCE METHODS

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

(2009) K Ray Chaudhuri et al.   LANCET NEUROLOGY

Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy

(2009) J. B. Goforth et al.   RNA

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

(2008) Catherine M. Cahill et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1

(2008) Catherine M. Cahill et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Early Parkinson’s disease and non-motor issues

(2008) K. Ray Chaudhuri et al.   JOURNAL OF NEUROLOGY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS